Natco Pharma (NSE:NATCOPHARM) Construction In Progress: ₹2,937 Mil (As of Mar. 2026)


NSE:NATCOPHARM Natco Pharma Ltd NSE:NATCOPHARM
90 GF Score
Price ₹932.00
GF Value ₹934.99
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Natco Pharma Construction In Progress?

Natco Pharma NSE:NATCOPHARM +0.06% 90 Construction In Progress is ₹2,937 Mil as of Mar. 2026. GuruFocus rates NSE:NATCOPHARM with a GF Score™ of 90/100 and a GF Value™ of ₹934.99 (Fairly Valued). The stock has 2 warning signs investors should review.

Natco Pharma's quarterly construction in progress declined from Sep. 2025 (₹2,552 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹2,937 Mil).

Natco Pharma's annual construction in progress increased from Mar. 2024 (₹2,063 Mil) to Mar. 2025 (₹2,742 Mil) and increased from Mar. 2025 (₹2,742 Mil) to Mar. 2026 (₹2,937 Mil).

Natco Pharma Construction In Progress Historical Data

* Premium members only.

The historical data trend for Natco Pharma's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Natco Pharma Construction In Progress Chart

Natco Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,761.00 912.00 2,063.00 2,742.00 2,937.00

Natco Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,742.00 0.00 2,552.00 0.00 2,937.00
NSE:NATCOPHARM
90GF Score
Natco Pharma Ltd NSE:NATCOPHARM
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Natco Pharma Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹2,937 Mil mean?
Natco Pharma (NSE:NATCOPHARM) has a Construction In Progress of ₹2,937 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Natco Pharma and its competitors.
Is Natco Pharma's Construction In Progress too high?
Natco Pharma's current Construction In Progress is ₹2,937 Mil. Overall, Natco Pharma has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Natco Pharma's Construction In Progress compare to ZTS and UTHR?
Natco Pharma's Construction In Progress of ₹2,937 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Natco Pharma and its competitors. Natco Pharma's current Construction In Progress is ₹2,937 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Natco Pharma stock overvalued right now?
Based on GuruFocus' analysis, Natco Pharma (NSE:NATCOPHARM) is currently considered Fairly Valued. The stock's GF Value™ is ₹934.99, compared to a current price of ₹932.00 — trading 0.3% below its estimated fair value. The current Construction In Progress is ₹2,937 Mil. Natco Pharma's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Natco Pharma (NSE:NATCOPHARM), the current Construction In Progress is ₹2,937 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Natco Pharma (NSE:NATCOPHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Natco Pharma stock appears to be undervalued. The current stock price of ₹932.00 is trading 0.3% below its estimated GF Value™ of ₹934.99. GuruFocus considers Natco Pharma to be Fairly Valued.

Key valuation signals for NSE:NATCOPHARM:

  • Construction In Progress: ₹2,937 Mil
  • GF Value™: ₹934.99 vs. price of ₹932.00 (0.3% below fair value)
  • GF Score™: 90/100 with 2 warning signs

No single metric tells the full story. See the NSE:NATCOPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Natco Pharma Business Description

Other Exchanges 524816:India
Address Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034
Natco Pharma Ltd is a drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. It derives maximum revenue from Pharmaceuticals Segment.
90GF Score

Get the complete analysis for NSE:NATCOPHARM

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹932.00
Price
₹934.99
GF Value